Declaration of conformity
Home
Company Information
Press Releases
Investor Relations
Our Products
Our R&D
Searching
Company Information
Company Profile
Milestones
Company Culture
Awards & Honors
Production Facility
Contact Us
Press Releases
Investor Relations
Stock Information
Financial Information
Leadership & Governance
FAQ
Email Alert
Our Products
Protective Products
CNS Cerebral & Cardio Vascular
Anti-Viral/Infection & Respiratory
Digestive Diseases
Other
Health Product
Our R&D
In-house R&D
Cooperative R&D
Coperate Social Responsibility
Your position :
Home
>
Press Releases
Press Releases
Press Releases
Aug. 5, 2021_China Pharma’s Candesartan Hypertension Product Passes Bioequivalen
2021-08-06
More details
June 9, 2021_China Pharma to Launch Highly Purified NMN+PQQ Product
2021-06-09
More details
May 14, 2021_China Pharma Holdings Inc. Reports 33% YoY Increase in First Quarte
2021-05-15
More details
April 19, 2021_China Pharma Expects Considerable Increase in Growth Opportunitie
2021-04-20
More details
Mar. 26, 2021_China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Res
2021-03-29
More details
Nov. 13, 2020_China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial R
2020-11-13
More details
Sep. 21, 2020_China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Cert
2020-09-21
More details
Aug. 14, 2020 - China Pharma Holdings, Inc. Reports Second Quarter 2020 Financia
2020-08-18
More details
MORE
1
2
3
4
5
Company Information
Company Profile
Milestones
Company Culture
Awards & Honors
Production Facility
Contact Us
Press Releases
Investor Relations
Stock Information
Financial Information
Leadership & Governance
FAQ
Email Alert
Our Products
Protective Products
CNS Cerebral & Cardio Vascular
Anti-Viral/Infection & Respiratory
Digestive Diseases
Other
Health Product
Our R&D
In-house R&D
Cooperative R&D
Coperate Social Responsibility
Contact Us
|
Company Profile
Copyright ©HAINAN HELPSON MEDICINE & BLOTECHNIQUE CO.,LTD All rights reserved
琼ICP备06001416号-2
SUPPORT BY:WWW.BUUGUU.COM